FCMC
Founders Capital Management (Connecticut) Portfolio holdings
AUM
$587M
This Quarter Return
+6.05%
1 Year Return
+14.61%
3 Year Return
+78.24%
5 Year Return
+130.13%
10 Year Return
+277.82%
AUM
$166M
AUM Growth
+$166M
(+7.2%)
Cap. Flow
-$295K
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
50.86%
Holding
55
New
1
Increased
26
Reduced
18
Closed
1
Top Buys
| 1 |
American Express
AXP
|
$621K |
| 2 |
Walmart
WMT
|
$511K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$434K |
| 4 |
AT&T
T
|
$290K |
| 5 |
Union Pacific
UNP
|
$273K |
Top Sells
| 1 |
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
|
$2.07M |
| 2 |
Mattel
MAT
|
$535K |
| 3 |
AbbVie
ABBV
|
$414K |
| 4 |
Medtronic
MDT
|
$267K |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$260K |
Sector Composition
| 1 | Healthcare | 20.32% |
| 2 | Consumer Staples | 15.06% |
| 3 | Technology | 14.32% |
| 4 | Industrials | 14.25% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AbbVie
ABBV
$374B
| $2.05M | 1.23% |
34,527
-6,987
| -17% | -$414K |
|
27
Abbott
ABT
$230B
| $1.98M | 1.19% |
44,038
-408
| -0.9% | -$18.3K |
|
28
Gilead Sciences
GILD
$140B
| $1.93M | 1.16% |
19,115
+50
| +0.3% | +$5.06K |
|
29
Amgen
AMGN
$153B
| $1.72M | 1.03% |
10,580
-155
| -1% | -$25.2K |
|
30
Exxon Mobil
XOM
$477B
| $1.47M | 0.88% |
18,793
+1,711
| +10% | +$133K |
|
|
31
Walmart
WMT
$793B
| $1.33M | 0.8% |
64,866
+25,035
| +63% | +$511K |
|
|
PTVCA
32
DELISTED
Protective Insurance Corporation Class A Common Stock
PTVCA
| $1.23M | 0.74% |
52,190
-2,085
| -4% | -$49.1K |
|
33
Lowe's Companies
LOW
$146B
| $799K | 0.48% |
10,513
| – | – |
|
34
United Parcel Service
UPS
$72.3B
| $774K | 0.47% |
8,041
+2,140
| +36% | +$206K |
|
35
Alphabet (Google) Class C
GOOG
$2.79T
| $573K | 0.35% |
14,960
+3,800
| +34% | +$146K |
|
36
GE Aerospace
GE
$293B
| $499K | 0.3% |
3,346
+422
| +14% | +$62.9K |
|
37
Apple
AAPL
$3.54T
| $417K | 0.25% |
15,848
+4,516
| +40% | +$119K |
|
38
Regeneron Pharmaceuticals
REGN
$59.8B
| $368K | 0.22% |
677
| – | – |
|
39
Halliburton
HAL
$18.4B
| $367K | 0.22% |
10,781
-111
| -1% | -$3.78K |
|
40
Sprott Physical Gold and Silver Trust
CEF
$6.46B
| $337K | 0.2% |
33,759
| – | – |
|
41
Cigna
CI
$80.2B
| $332K | 0.2% |
2,268
| – | – |
|
42
3M
MMM
$81B
| $286K | 0.17% |
2,272
+9
| +0.4% | +$1.13K |
|
|
RTN
43
DELISTED
Raytheon Company
RTN
| $282K | 0.17% |
2,267
+13
| +0.6% | +$1.62K |
|
44
Bristol-Myers Squibb
BMY
$96.7B
| $274K | 0.17% |
3,979
-1,455
| -27% | -$100K |
|
|
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $273K | 0.16% |
5,965
-5,685
| -49% | -$260K |
|
46
JPMorgan Chase
JPM
$824B
| $250K | 0.15% |
3,787
+22
| +0.6% | +$1.45K |
|
|
BHI
47
DELISTED
Baker Hughes
BHI
| $246K | 0.15% |
5,325
| – | – |
|
48
Oracle
ORCL
$628B
| $209K | 0.13% |
+5,720
| New | +$209K |
|
|
49
Berkshire Hathaway Class A
BRK.A
$1.08T
| $198K | 0.12% |
1
| – | – |
|
50
Enterprise Products Partners
EPD
$68.9B
| $178K | 0.11% |
6,950
+164
| +2% | +$4.2K |
|